Dr. Fabien Maldonado, MD

Dr. Maldonado practices at Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center.

Dr. Maldonado's NPI, 1437161221, was assigned on August 12, 2006. Dr. Maldonado holds Tennessee license MD52625.

Dr. Maldonado's primary practice is Vanderbilt University Medical Center, at 1211 Medical Center Drive, Nashville, TN 37232 in Davidson County. The practice phone is (615) 322-3454.

Dr. Maldonado's primary practice is Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center. Dr. Maldonado is also affiliated with Vanderbilt Wilson County Hospital. The medical group on file is Vanderbilt University Medical Center. Dmand AI also links Dr. Maldonado to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Maldonado practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Maldonado's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dmand AI has Dr. Maldonado's licenses on file in 2 states: Tennessee and Minnesota.

CMS data shows 414 Medicare services from Dr. Maldonado across 10 procedure codes in 2024, for 212 Medicare patients. Medicare paid $36,325 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 212 Medicare patients who saw Dr. Maldonado in 2024. The largest group is 65 to 74, with 117 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Maldonado's median patient age at 70, with 49% women.

In 2024, Dr. Maldonado wrote 35 Medicare Part D claims for 16 patients. 51% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $79 in total drug cost. In 2019, CMS named 14 claims across 1 drug.

Dr. Maldonado accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Maldonado as offering telehealth.

Dmand AI links 116 papers to Dr. Maldonado, published from 2019 to 2025. 2023 was the busiest year, with 33. The most frequent topics are Lung Neoplasms, Bronchoscopy and Lung. Dr. Maldonado has published most often in Chest. Dr. Maldonado's most frequent co-authors are Robert James Lentz, MD, Kim Lori Sandler, MD and Lonny Yarmus, DO.

CMS Open Payments shows 171 general payments to Dr. Maldonado from 16 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 45% of the total. Covidien LP paid the most, $36,031. It also lists 1 research payment totaling $1,290 in 2020.